Literature DB >> 16397312

Establishment of reference values for endocrine tests. Part IV: Adrenal insufficiency.

E Endert1, A Ouwehand, E Fliers, M F Prummel, W M Wiersinga.   

Abstract

BACKGROUND: The short Synacthen test, the overnight metyrapone test and the insulin tolerance test are frequently used in the evaluation of patients suspected of adrenal insufficiency. in the present study, we established reference values for these diagnostic tests, as well as for baseline morning plasma cortisol and adrenocorticotrophic hormone (ACTH).
METHODS: We studied 50 subjects recruited from the general population, equally distributed according to sex and age between 20 and 69 years. A short ACTH stimulation test (250 microg Synacthen iv), an overnight metyrapone test (2.0, 2.5, or 3.0 g given orally depending on body weight at 23.30 hours) and an insulin tolerance test (0.15 U/kg actrapid iv) were performed. Reference intervals are given as the means +/- 2SD of observed hormone concentrations after logarithmic transformation.
RESULTS: The following reference values were established: 09.00 hr plasma cortisol 150 to 802 nmol/l, 09.00 hr plasma ACTH 8 to 93 ng/l, peak plasma cortisol after Synacthen 591 to 1,113 nmol/l, peak plasma cortisol after insulin-induced hypoglycaemia 557 to 1,015 nmol/l, and plasma 11-deoxycortisol after metyrapone 197 to 759 nmol/l.
CONCLUSION: We established reference values for diagnostic tests that are useful in the evaluation of patients suspected of primary or secondary/tertiary adrenal insufficiency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16397312

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  7 in total

Review 1.  Anterior pituitary hormone replacement therapy--a clinical review.

Authors:  Christoph J Auernhammer; George Vlotides
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

2.  Pituitary testing: a reappraisal.

Authors:  Andrea Giustina
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

3.  Characterization of the serum and salivary cortisol response to the intravenous 250 µg ACTH1-24 stimulation test.

Authors:  Brendan J Nolan; Jane Sorbello; Nigel Brown; Goce Dimeski; Warrick J Inder
Journal:  Endocrine       Date:  2018-01-03       Impact factor: 3.633

4.  Central adrenal insufficiency and diabetes insipidus misdiagnosed as severe depression.

Authors:  Naoki Hiroi; Aya Yoshihara; Mariko Sue; Gen Yoshino; Mariko Higa
Journal:  Clin Med Insights Case Rep       Date:  2010-09-27

Review 5.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2016-01-13       Impact factor: 5.958

6.  Hypothalamic-pituitary-adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients.

Authors:  Femke Besemer; Cornelis Kramers; Kees Brinkman; Ad R M M Hermus; Antonius E van Herwaarden; David M Burger
Journal:  Int J Clin Pharm       Date:  2020-03-05

7.  Central Adrenal Insufficiency Is Rare in Adults With Prader-Willi Syndrome.

Authors:  Anna G W Rosenberg; Karlijn Pellikaan; Christine Poitou; Anthony P Goldstone; Charlotte Høybye; Tania Markovic; Graziano Grugni; Antonino Crinò; Assumpta Caixàs; Muriel Coupaye; Sjoerd A A Van Den Berg; Aart Jan Van Der Lely; Laura C G De Graaff
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.